Translational Medicine and Drug Discovery
Editat de Bruce H. Littman MD, Rajesh Krishna PhD, FCPen Limba Engleză Paperback – 29 oct 2014
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 448.70 lei 6-8 săpt. | |
Cambridge University Press – 29 oct 2014 | 448.70 lei 6-8 săpt. | |
Hardback (1) | 721.72 lei 6-8 săpt. | |
Cambridge University Press – 30 ian 2011 | 721.72 lei 6-8 săpt. |
Preț: 448.70 lei
Preț vechi: 472.31 lei
-5% Nou
Puncte Express: 673
Preț estimativ în valută:
85.87€ • 88.97$ • 71.66£
85.87€ • 88.97$ • 71.66£
Carte tipărită la comandă
Livrare economică 21 martie-04 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781107435940
ISBN-10: 1107435943
Pagini: 384
Ilustrații: 49 b/w illus. 16 tables
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.66 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:New York, United States
ISBN-10: 1107435943
Pagini: 384
Ilustrații: 49 b/w illus. 16 tables
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.66 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:New York, United States
Cuprins
Part I. Translational Medicine: History, Principles and Application in Drug Development: 1. Overview of translational medicine and drug development Bruce H. Littman; 2. Concepts and case studies: diabetes Ann Taylor and Roberto Calle; 3. Challenges in atherosclerosis John Millar; 4. Obesity: new mechanisms and translational paradigms Gregory Gaich and David E. Moller; 5. Bone disorders: case studies of translational research S. Aubrey Stoch; 6. Case studies in neuroscience: unique challenges and examples Gerard J. Marek; 7. Translational medicine in oncology Dominic G. Spinella; Part II. Biomarkers and Public-Private Partnerships: 8. Biomarker validation and application in drug development Pfizer Global Research and Development; 9. Application of imaging methods in translational medicine Johannes T. Tauscher and Adam Schwarz; 10. European innovative medicines initiative Ole J. Bjerrum and Hans H. Linden; 11. Critical path institute and the predictive safety consortium Elizabeth Gribble Walker; 12. The biomarker consortium David B. Lee; Part III. Future Directions: 13. Improving the quality and productivity of pharmacometric modeling and simulation activities - the foundation for model-based drug development Thaddeus H. Grasela, Jill Fiedler-Kelly and Robert Slusser; 14. Embracing change: a pharmaceutical industry guide to the 21st century Mervyn Turner.
Recenzii
'This is an important book in a relatively new and growing field. Anyone engaged in advanced research designed to bring new drugs and biologics to market will find it valuable.' Drug Information Journal
Descriere
This book focuses on the new discipline of translational medicine as it pertains to drug development within the pharmaceutical and biotechnology industry.